Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in Children.

Autor: Huang RS; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Nephrology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., McMahon KR; Division of Nephrology, Department of Pediatrics, Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Wang S; Division of Nephrology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Chui H; Division of Nephrology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.; Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada., Lebel A; Division of Nephrology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Lee J; Division of Nephrology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Cockovski V; Division of Nephrology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Rassekh SR; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Schultz KR; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Blydt-Hansen TD; Division of Pediatric Nephrology, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Cuvelier GDE; Department of Pediatric Hematology-Oncology-BMT, CancerCare Manitoba, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Mammen C; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Pinsk M; Section of Pediatric Nephrology, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada., Carleton BC; Division of Translational Therapeutics, Department of Pediatrics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Tsuyuki RT; Departments of Pharmacology and Medicine, Faculty of Medicine and Dentistry, EPICORE Centre, University of Alberta, Edmonton, Alberta, Canada., Ross CJD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Palijan A; Division of Nephrology, Department of Pediatrics, Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Zappitelli M; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Nephrology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Jazyk: angličtina
Zdroj: Kidney360 [Kidney360] 2024 Jun 01; Vol. 5 (6), pp. 821-833. Date of Electronic Publication: 2024 Apr 26.
DOI: 10.34067/KID.0000000000000448
Databáze: MEDLINE